Stocksigma LogoStocksigma Logo

Venus Remedies Schedules Board Meeting to Approve Q2 Results

Venus Remedies Limited has scheduled its Board of Directors meeting on 26th Oct'26 to consider and approve the unaudited standalone and consolidated

Venus Remedies Schedules Board Meeting to Approve Q2 Results

Venus Remedies Ltd 路 Intimation 路 26 Oct 2026, 5:30 am

Venus Remedies Schedules Board Meeting to Approve Q2 Results Venus Remedies Limited has scheduled its Board of Directors meeting on 26th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons has been closed from 1st Oct'26 and will remain shut until 48 hours following the formal declaration of the financial results.

Original exchange filing (PDF)

More announcements from Venus Remedies Ltd

All Venus Remedies Ltd announcements